Relationship between tumor necrosis factor-α and cardiac enzyme in children with pneumonia
FENG Lin, HU Xian, GONG Xin-Peng
Abstract No abstract available
Cite this article:
FENG Lin,HU Xian,GONG Xin-Peng. Relationship between tumor necrosis factor-α and cardiac enzyme in children with pneumonia[J]. 中国当代儿科杂志, 2001, 3(4): 409-410.
FENG Lin,HU Xian,GONG Xin-Peng. Relationship between tumor necrosis factor-α and cardiac enzyme in children with pneumonia[J]. CJCP, 2001, 3(4): 409-410.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2001/V3/I4/409
[1]
XIAO Tian-Tian, JIN Mei, JU Rong, YANG Sheng, GAO Shu-Qiang, JIANG Yan, ZHANG Xiao-Long. Value of bedside lung ultrasound in the diagnosis of neonatal pneumonia
[2]
CAO Li-Jie, LIU Jian-Hua, SHUAI Jin-Feng, NIU Bo, LU Su-Kun, HUANG Kun-Ling. Efficacy of early treatment via fiber bronchoscope in children with Mycoplasma pneumoniae pneumonia complicated by airway mucus obstruction
[3]
CHEN Qi-Fen, ZHANG Yi-Wei. Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia
[4]
HU Nan, LI Qu-Bei, ZOU Shan-Ye. Effect of vitamin A as an adjuvant therapy for pneumonia in children: a Meta analysis
[5]
LIU Chang, JING Ke. Effects of Toll-like receptor blockers on intestinal mucosal injury in mice with endotoxemia
[6]
FENG Bo-Wen, FU Si-Mao, ZHANG Quan-Shan, LOGN Xiao-Ling, XIE Guang-Qing, REN Wei, LIANG Zhan-Tu, YANG Zhu-Ling, CHEN Ang. Influence of cow's milk protein allergy on the diagnosis of functional gastrointestinal diseases based on the Rome IV standard in infants and young children
[7]
WU Zhong-Jing, CHEN Ya-Feng, WANG Hai-Dao, GAO Fang-Hong. Expression of plasma miRNA-497 in children with sepsis-induced myocardial injury and its clinical significance
[8]
XU Jiang-Jiang, SHU Lin-Hua. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children
[9]
LU Yun-Yun, LUO Rong, FU Zhou. Pathogen distribution and bacterial resistance in children with severe community-acquired pneumonia
[10]
LIU Jin, YAN Hong, CHEN Xiao-Geng, MU Ya-Ping. Effects of Huaiqihuang granules on immune function in children with severe Mycoplasma pneumoniae pneumonia
[11]
SHEN Dong-Dong, YUAN Fei, HOU Jiang-Hong. Effect of annexin A2 on EGFR/NF-κB signal transduction and mucin expression in human airway epithelial cells treated with Mycoplasma pneumoniae
[12]
ZHANG Jing, CUI Ya-Li, JIANG Yong-Mei. Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection
[13]
MA Wei-Yin, PENG Shao, ZHANG Ting. Changes in serum YKL-40 level and humoral immune function and their significance in children with recurrent pneumonia
[14]
WANG Shou-Gui, ZHANG Xiang-Sheng, ZHAO Yan-Fang, SUN Li, PAN Xi-Tao, WAN Ning. Risk factors for allergic diseases in children aged 0-24 months in the Wuhu urban area, Anhui Province, China
[15]
GUO Xiao-Hui, SUN Yan-Feng, WANG Jiang-Bo, HAN Shu-Zhen, MIAO Jing, CUI Min. Value of nutritional risk screening in evaluating adverse clinical outcomes in children with severe pneumonia
